Proton magnetic resonance spectroscopy for metabolic characterization of plaques in multiple sclerosis.
about
Magnetic resonance spectroscopy of normal appearing white matter in early relapsing-remitting multiple sclerosis: correlations between disability and spectroscopyMyalgic encephalomyelitis/chronic fatigue syndrome and encephalomyelitis disseminata/multiple sclerosis show remarkable levels of similarity in phenomenology and neuroimmune characteristicsCharacterization of tissue damage in multiple sclerosis by nuclear magnetic resonance.Studies of human tumors by MRS: a review.Changes observed in multiple sclerosis using magnetic resonance imaging reflect a focal pathology distributed along axonal pathways.MR spectroscopy in neurodegenerative disease.Recent advances in magnetic resonance neurospectroscopy.Proton magnetic resonance spectroscopy in brain white matter disorders.Magnetic resonance spectroscopy in vivo: applications in neurological disorders.Does the extent of axonal loss and demyelination from chronic lesions in multiple sclerosis correlate with the clinical subgroup?Magnetic resonance spectroscopic study of parkinsonism related to boxing.Therapeutic plasma exchange for acute inflammatory demyelinating syndromes of the central nervous system.A neonatal piglet model for investigating brain and cognitive development in small for gestational age human infants.Axonal damage in multiple sclerosis.A patient develops transient unique cerebral and cerebellar lesions after unruptured aneurysm coiling.Differentiation and quantification of inflammation, demyelination and axon injury or loss in multiple sclerosis.1H-MRS in patients with multiple sclerosis undergoing treatment with interferon beta-1a: results of a preliminary study.Localised 1H-MR spectroscopy for metabolic characterisation of diffuse and focal brain lesions in patients infected with HIV.White matter abnormalities in patients with treated hyperphenylalaninaemia: magnetic resonance relaxometry and proton spectroscopy findings.Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis. US National MS Society Task Force.In vivo quantitation of metabolite concentrations in the brain by means of proton MRS.Guidelines for MRI monitoring of the treatment of multiple sclerosis: recommendations of the US Multiple Sclerosis Society's task force.Postnatal Iron Deficiency Alters Brain Development in Piglets.Metabolic alterations in Parkinson's disease after thalamotomy, as revealed by 1H MR spectroscopy.Localized proton NMR spectroscopy in the striatum of patients with idiopathic Parkinson's disease: a multicenter pilot study.Proton magnetic resonance spectroscopy in Parkinson's disease and progressive supranuclear palsy.Proton MR spectroscopic findings in paroxysmal kinesigenic dyskinesia.Choline containing metabolites during cell transfection: an insight into magnetic resonance spectroscopy detectable changes.MRI white matter hyperintensities, (1)H-MR spectroscopy and cognitive function in geriatric depression: a comparison of early- and late-onset cases.What might be the impact on neurology of the analysis of brain metabolism by in vivo magnetic resonance spectroscopy?Detection and differentiation of lactate and lipids by single-voxel proton MR spectroscopy.Long-term study of brain 1H-MRS study in multiple sclerosis: effect of glatiramer acetate therapy on axonal metabolic function and feasibility of long-Term H-MRS monitoring in multiple sclerosis.Metabolite changes in early relapsing-remitting multiple sclerosis. A two year follow-up study.Axonal metabolic recovery and potential neuroprotective effect of glatiramer acetate in relapsing-remitting multiple sclerosis.Axonal damage in the spinal cord of multiple sclerosis patients detected by magnetic resonance spectroscopy.Use of proton magnetic resonance spectroscopy for monitoring disease progression in multiple sclerosis.Localized proton spectroscopy of focal brain pathology in humans: significant effects of edema on spin-spin relaxation time.Histopathology and serial, multimodal magnetic resonance imaging in a multiple sclerosis variant.Proton magnetic resonance spectroscopy (1H MRS) in patients with sporadic cerebellar degeneration.The proton NMR spectrum in acute EAE: the significance of the change in the Cho:Cr ratio.
P2860
Q24800569-4686A8F8-6FF6-480E-B368-3B38412ED1F1Q26998412-ADA1E642-F63E-4902-B9F3-F2F76E9E3D30Q30585635-9A0126FE-B6C6-4A07-8AB4-7685FA0248DFQ30833628-A1268FBF-E875-4489-890B-170E37FC00C5Q31014030-4AD354FA-8FB7-462C-898F-149FCC4DD4C5Q31097717-BC533135-1872-4257-8A88-37FD350871F4Q31117145-F43FCD18-91B0-49DE-B544-E20B9D43D697Q32101259-489C9686-13BF-4A04-A722-705272547DFEQ32101276-1799CF8E-FA32-4995-B586-3B7C3921B1D5Q33179184-E73A9C4A-8FC0-46A1-9BEB-F9FD096E021DQ33734268-30609C8F-B844-4F77-9EDD-59DD9FD487C2Q33762558-8957D4EF-78BA-4BBF-9D9F-13A7AD879E61Q35122979-F3EBBFA4-60DA-4761-B5FA-B1CAA97F33A4Q35126104-027B7D0B-A9F5-47DA-AD39-92979AAA6D7DQ35294135-AF0F7159-7099-4B5D-A19C-22907437E4C2Q35529707-E61BE482-E9B1-4185-B41C-BD001B1B761BQ36317738-75C31EC0-92EE-49BC-B3DD-318BDACB7DD2Q36318124-C65CFA5A-F7B3-442B-BA88-1437EBB1DFA3Q36745071-4FFC33D2-C1EB-4084-AABE-D164969E80A5Q36792204-903F15D1-9666-41A7-8C3C-14CD7D97120EQ36815363-60B5513B-EFB6-4010-82E7-68E84FE5474DQ36887909-D75C8037-3D86-4B7B-B06C-00C39497D001Q37051690-8D6C2CDF-A9A6-4D71-B1FB-F055A2C4BABAQ37270201-CEED42E7-B5E5-4088-A215-CC0B4701BF13Q41673613-6FCFB2AC-2FB0-45D9-B812-F7249363959BQ41847841-4EB115A8-1F86-44AF-BAF3-8E636891EF44Q42541981-052F489C-63B2-4B75-922D-0EA7922BA675Q43821377-1770AB0B-9A4D-4089-B7AF-D2147F924290Q43827146-06C9C819-2431-4762-9D1C-1EA70D6A3345Q45257760-A9F90420-EFF1-4FA2-8730-AAECDBA488CBQ46679355-B1B9FB03-1644-4796-A035-2F1386028E5AQ46730726-9BA502AB-E909-4BCF-84C3-166AFA1BED0DQ46819434-6CBFA839-B24E-4064-869D-F926CF37AE9FQ46829890-5DC8AF63-B7B5-4035-B2FB-B2FB02B5E6EFQ46924918-34A80A44-3C37-46B6-9629-446A8243B181Q48093875-0888BCC2-5507-4B19-9BA8-474838DE264DQ48133268-FE8167CE-B982-4685-B2A3-9A0A5F7943FFQ48186713-4BB85A7A-DC71-48C1-A35C-0E951190B757Q48234826-64F3DC3F-582E-45A2-A578-9ADB027158D6Q48274750-1FA926A4-F6F9-4FEC-8650-FC728E83321A
P2860
Proton magnetic resonance spectroscopy for metabolic characterization of plaques in multiple sclerosis.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年学术文章
@wuu
1991年学术文章
@zh
1991年学术文章
@zh-cn
1991年学术文章
@zh-hans
1991年学术文章
@zh-my
1991年学术文章
@zh-sg
1991年學術文章
@yue
1991年學術文章
@zh-hant
name
Proton magnetic resonance spec ...... plaques in multiple sclerosis.
@en
Proton magnetic resonance spec ...... plaques in multiple sclerosis.
@nl
type
label
Proton magnetic resonance spec ...... plaques in multiple sclerosis.
@en
Proton magnetic resonance spec ...... plaques in multiple sclerosis.
@nl
prefLabel
Proton magnetic resonance spec ...... plaques in multiple sclerosis.
@en
Proton magnetic resonance spec ...... plaques in multiple sclerosis.
@nl
P2093
P356
P1433
P1476
Proton magnetic resonance spec ...... plaques in multiple sclerosis.
@en
P2093
P304
P356
10.1212/WNL.41.8.1251
P407
P577
1991-08-01T00:00:00Z